1. From the Division of Hematology, the Institute of Experimental Endocrinology and Oncology (National Research Council) and the Department of Cellular and Molecular Biology and Pathology, “Federico II” University, Naples; the Department of Experimental Oncology, National Cancer Institute, Naples; and the Molecular Genetics Unit, Department of Cell Biology and Functional Genomics, University “Vita-Salute San Raffaele” and IFOM (Firc Institute of Molecular Oncology), Milan, Italy.